zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Comparative studies of urolithins and their phase II metabolites on macrophage and neutrophil functions (2021)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Bobowska, Aneta
    Grancia, Sebastian
    Filipek, Agnieszka
    Melzig, Matthias F.
    Moeslinger, Thomas
    Zentek, Jürgen (WE 4)
    Kruk, Aleksandra
    Piwowarski, Jakub P. (WE 4)
    Quelle
    European journal of nutrition
    Bandzählung: 60
    Heftzählung: 4
    Seiten: 1957 – 1972
    ISSN: 1436-6215
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://link.springer.com/article/10.1007/s00394-020-02386-y
    DOI: 10.1007/s00394-020-02386-y
    Pubmed: 32960290
    Kontakt
    Institut für Tierernährung

    Königin-Luise-Str. 49
    14195 Berlin
    +49 30 838 52256
    tierernaehrung@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Purpose
    Ellagitannins are high molecular weight polyphenols present in high quantities in various food products. They are metabolized by human and animal gut microbiota to postbiotic metabolites-urolithins, bioavailable molecules of a low molecular weight. Following absorption in the gut, urolithins rapidly undergo phase II metabolism. Thus, to fully evaluate the mechanisms of their biological activity, the in vitro studies should be conducted for their phase II conjugates, mainly glucuronides. The aim of the study was to comparatively determine the influence of urolithin A, iso-urolithin A, and urolithin B together with their respective glucuronides on processes associated with the inflammatory response.

    Methods
    The urolithins obtained by chemical synthesis or isolation from microbiota cultures were tested with their respective glucuronides isolated from human urine towards modulation of inflammatory response in THP-1-derived macrophages, RAW 264.7 macrophages, PBMCs-derived macrophages, and primary neutrophils.

    Results
    Urolithin A was confirmed to be the most active metabolite in terms of LPS-induced inflammatory response inhibition (TNF-α attenuation, IL-10 induction). The observed strong induction of ERK1/2 phosphorylation has been postulated as the mechanism of its action. None of the tested glucuronide conjugates was active in terms of pro-inflammatory TNF-α inhibition and anti-inflammatory IL-10 and TGF-β1 induction.

    Conclusion
    Comparative studies of the most abundant urolithins and their phase II conjugates conducted on human and murine immune cells unambiguously confirmed urolithin A to be the most active metabolite in terms of inhibition of the inflammatory response. Phase II metabolism was shown to result in the loss of urolithins’ pharmacological properties.